21 results on '"Wynand J. Goosen"'
Search Results
2. Mycobacterium tuberculosis complex detection in rural goat herds in South Africa using Bayesian latent class analysis
- Author
-
Deborah M. Cooke, Wynand J. Goosen, Tristan Burgess, Carmel Witte, and Michele A. Miller
- Subjects
General Veterinary ,Immunology - Published
- 2023
3. Diagnosis of Mycobacterium bovis infection in free‐ranging common hippopotamus ( Hippopotamus amphibius )
- Author
-
Tanya J. Kerr, Robin M. Warren, Oonagh Pretorius, Konstantin P. Lyashchenko, Peter Buss, Paul D. van Helden, Lin-Mari de Klerk-Lorist, Michele A. Miller, Wynand J. Goosen, Léanie Kleynhans, and Rachiel Gumbo
- Subjects
Mycobacterium bovis ,General Veterinary ,General Immunology and Microbiology ,biology ,Free ranging ,Wildlife ,Cattle Diseases ,Zoology ,General Medicine ,biology.organism_classification ,Hippopotamus amphibius ,Serology ,Interspecies transmission ,Seroepidemiologic Studies ,biology.animal ,Hippopotamus ,Animals ,Tuberculosis ,Seroprevalence ,Cattle ,Tuberculosis, Bovine ,Ecosystem ,Artiodactyla ,Retrospective Studies - Abstract
Bovine tuberculosis (bTB), caused by Mycobacterium bovis (M. bovis) infection, is a multi-host disease which negatively affects the wildlife industry, with adverse consequences for conservation, ecotourism, and game/wildlife sales. Although interspecies transmission has been reported between some wildlife hosts, the risk of spread in complex ecosystems is largely unknown. As a controlled disease, tools for accurate detection of M. bovis infection are crucial for effective surveillance and management, especially in wildlife populations. There are, however, limited species-specific diagnostic tests available for wildlife. Hippopotamuses are rarely tested for M. bovis infection, and infection has not previously been confirmed in these species. In this study, blood and tissue samples collected from common hippopotamus (Hippopotamus amphibius) residing in a bTB-endemic area, the Greater Kruger Protected area (GKPA), were retrospectively screened to determine whether there was evidence for interspecies transmission of M. bovis, and identify tools for M. bovis detection in this species. Using the multi-species DPP® VetTB serological assay, a bTB seroprevalence of 8% was found in hippopotamus from GKPA. In addition, the first confirmed case of M. bovis infection in a free-ranging common hippopotamus is reported, based on the isolation in mycobacterial culture, genetic speciation and detection of DNA in tissue samples. Importantly, the M. bovis spoligotype (SB0121) isolated from this common hippopotamus is shared with other M. bovis-infected hosts in GKPA, suggesting interspecies transmission. These results support the hypothesis that M. bovis infection may be under recognized in hippopotamus. Further investigation is needed to determine the risk of interspecies transmission of M. bovis to common hippopotamus in bTB-endemic ecosystems and evaluate serological and other diagnostic tools in this species.
- Published
- 2021
4. Field evaluation of the tuberculin skin test for the detection of Mycobacterium tuberculosis complex infection in communal goats (Capra hircus) in KwaZulu-Natal, South Africa
- Author
-
Deborah M. Cooke, Wynand J. Goosen, Carmel Witte, and Michele A. Miller
- Subjects
Goat Diseases ,General Veterinary ,Buffaloes ,Tuberculin Test ,Goats ,Immunology ,Cattle Diseases ,Mycobacterium tuberculosis ,Tuberculin ,Mycobacterium bovis ,South Africa ,Animals ,Humans ,Tuberculosis ,Cattle ,Tuberculosis, Bovine - Abstract
In South Africa, animal tuberculosis (TB) control programs predominantly focus on domestic cattle and African buffaloes (Syncerus caffer) despite increasing global reports of tuberculosis in goats (Capra hircus). Left undetected, Mycobacterium tuberculosis complex (MTBC) infected goats may hinder TB eradication efforts in cattle and increase zoonotic risk to humans. Since the publication of animal TB testing guidelines in 2018, prescribing the use of the tuberculin skin test (TST) for goats in South Africa by the Department of Agriculture, Land Reform, and Rural Development (DALRRD), there have been no published reports of any field application of the prescribed test criteria in goat herds. Therefore, this study aimed to evaluate the performance of these DALRRD guidelines using the single intradermal cervical tuberculin test (SICT) and the single intradermal comparative cervical tuberculin test (SICCT). Between October and December 2020, 495 goats from communal pastures of Kwa-Zulu Natal (KZN), where M. bovis infection has been identified in cattle and where cattle and goats cohabitate, were tested using the SICT and SICCT (M. bovis-exposed group). Additionally, 277 goats from a commercial Saanen dairy herd, with no history of M. bovis, were also tested (M. bovis-unexposed group). Estimated apparent prevalence of TST positive goats was determined based on published test interpretation criteria as described by DALRRD. When proportions of test-positive goats were compared between different DALRRD criteria, the ≥ 4 mm cut-off criterion for the SICCT resulted in the lowest proportion of positive results in the presumably uninfected group (1/277 positive in the unexposed group). The apparent prevalence of TB in the exposed group was estimated at 3.0% (95% CI: 1.7-4.9%), which is similar to previous reports of M. bovis prevalence in cattle from this area (6%). The detection of a significantly greater proportion of SICCT positive goats in the M. bovis-exposed group compared to the unexposed group suggests that MTBC infection is present in this population. Further investigations should be undertaken, in conjunction with confirmatory molecular tests, mycobacterial culture, and advanced pathogen sequencing to establish whether MTBC infection in domestic goats is a true under-recognized threat to the eradication of animal TB in South Africa.
- Published
- 2022
5. CYTOKINE-RELEASE ASSAY FOR THE DETECTION OF MYCOBACTERIUM BOVIS INFECTION IN CHEETAH (ACINONYX JUBATUS)
- Author
-
Rachiel Gumbo, Elin Crockett, Wynand J. Goosen, Robin M. Warren, Paul D. van Helden, Michele A. Miller, and Tanya J. Kerr
- Subjects
General Veterinary ,Animal Science and Zoology ,General Medicine - Published
- 2021
6. Reduced capability of refrigerated white rhinoceros whole blood to produce interferon-gamma upon mitogen stimulation
- Author
-
Rebecca, Dwyer, Carmel, Witte, Peter, Buss, Tebogo, Manamela, Leana, Freese, Guy, Hausler, Wynand J, Goosen, and Michele, Miller
- Subjects
Male ,Interferon-gamma ,General Veterinary ,Immunology ,Animals ,Tuberculosis ,Pilot Projects ,Mycobacterium tuberculosis ,Mitogens ,Interferon-gamma Release Tests ,Perissodactyla - Abstract
Ante-mortem surveillance for Mycobacterium bovis (M. bovis) infection in the Kruger National Park (KNP) rhinoceros population currently relies on results from the QuantiFERON-TB Gold (In-Tube) Plus (QFT)-interferon gamma (IFN-γ) release assay (IGRA). However, same-day processing of rhinoceros blood samples for this test is a logistical challenge. Therefore, a pilot study was performed to compare mitogen-stimulated and unstimulated IFN-γ concentrations in plasma from rhinoceros whole blood processed within 6 h of collection or stored at 4°C for 24 and 48 h prior to incubation in QFT tubes. Replicate samples of heparinized whole blood from seven subadult male white rhinoceros were used. Results showed no change in IFN-γ levels in unstimulated samples, however the relative concentrations of IFN-γ (based on optical density values) in mitogen plasma decreased significantly with increased time blood was stored post-collection and prior to QFT stimulation. These findings support a need for same-day processing of rhinoceros blood samples for QFT-IGRA testing as per the current practice. Further investigation using TB-antigen stimulated samples is warranted to properly assess the impact of blood storage on TB test results in rhinoceros.
- Published
- 2022
7. A commercial ELISA for detection of interferon gamma in white rhinoceros
- Author
-
Paul D. van Helden, Wynand J. Goosen, Josephine Chileshe, Sven D.C. Parsons, Robin M. Warren, Michele A. Miller, and Peter Buss
- Subjects
Population ,Enzyme-Linked Immunosorbent Assay ,Rhinoceros ,Interferon-gamma ,South Africa ,medicine ,Animals ,Tuberculosis ,Interferon gamma ,Full Scientific Reports ,education ,Perissodactyla ,Detection limit ,Mycobacterium bovis ,education.field_of_study ,General Veterinary ,biology ,Ceratotherium simum ,Reproducibility of Results ,biology.organism_classification ,Virology ,White (mutation) ,biology.protein ,Antibody ,medicine.drug - Abstract
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is endemic in Kruger National Park, South Africa, home to the largest population of white rhinoceros ( Ceratotherium simum) in the world. In 2016, the first cases of naturally occurring bTB were reported in white rhinoceros; however, there is a lack of understanding of infection and disease process in this species. Prevention and control of transmission depends on the availability of accurate tools to detect M. bovis infection. Interferon gamma (IFN-γ) assays are a reliable detection method for TB in other animal species, and studies have indicated that these tests can be used in white rhinoceros. We sought to screen and optimize a commercial IFN-γ enzyme-linked immunosorbent assay (ELISA) to detect endogenous white rhinoceros IFN-γ in mitogen-stimulated whole blood as a basis for developing a test for M. bovis infection. Optimizations included identifying ELISA antibodies and determining the effect of sample matrix, ELISA plate incubation temperature, ELISA linearity, assay reproducibility, and the assay’s limit of quantification. The optimized assay employed an equine IFN-γ antibody pair that was used to create a commercial ELISA kit. This ELISA had a linear response to recombinant equine and endogenous rhinoceros IFN-γ (range: 7.8–125 pg/mL). When incubated at 37°C, the ELISA was highly reproducible, with an optimal recovery and a low limit of quantification, indicating that the Mabtech equine IFN-γ ELISAPRO kit is a robust assay for measuring white rhinoceros IFN-γ.
- Published
- 2019
8. Shedding of Mycobacterium bovis in respiratory secretions of free-ranging wild dogs (Lycaon pictus): Implications for intraspecies transmission
- Author
-
Marlo Möller, Christina Meiring, Louis van Schalkwyk, Lin-Mari de Klerk-Lorist, Michele A. Miller, Peter Buss, Roxanne L. Higgitt, Wynand J. Goosen, Sven D.C. Parsons, and Paul D. van Helden
- Subjects
040301 veterinary sciences ,Parks, Recreational ,Interferon gamma release assay ,Cattle Diseases ,Microbiology ,0403 veterinary science ,03 medical and health sciences ,Immune system ,medicine ,Ingestion ,Animals ,Tuberculosis ,Respiratory system ,030304 developmental biology ,0303 health sciences ,Mycobacterium bovis ,General Veterinary ,General Immunology and Microbiology ,medicine.diagnostic_test ,biology ,Transmission (medicine) ,04 agricultural and veterinary sciences ,General Medicine ,biology.organism_classification ,Lycaon pictus ,Bronchoalveolar lavage ,Cattle ,Tuberculosis, Bovine ,Interferon-gamma Release Tests - Abstract
It has recently been discovered that Mycobacterium bovis (M. bovis) causes disease in the endangered African wild dog (Lycaon pictus) in areas endemic for bovine tuberculosis (bTB), including the Kruger National Park (KNP). However, information on M. bovis infection dynamics within this species is limited and requires investigation as M. bovis can cause conservation consequences due to movement restrictions, crucial for genetic management. This study had two aims: firstly, to investigate mycobacterial shedding in free-ranging wild dogs from KNP by culturing oropharyngeal swab (OS) and bronchoalveolar lavage (BAL) samples. Secondly, to determine the relationship between ante-mortem culture and interferon gamma release assay (IGRA) results as well as agreement between OS culture and BAL culture results. Mycobacterial culture revealed that 6 of 173 (3.5%) OS samples and 1 of 32 (3.1%) BAL samples (from 7 different wild dogs) were M. bovis culture positive, suggesting that wild dogs can shed M. bovis through respiratory secretions. However, the possibility of contamination by ingestion of infected prey cannot be excluded in wild dogs with positive OS culture results. Furthermore, the test outcomes between IGRA and culture (OS and BAL) differed substantially. Samples from 172 wild dogs were available for IGRA screening and 134 had positive results (detectable M. bovis immune sensitization). Seven wild dogs had culture-positive results, which included one additional wild dog that did not have an IGRA result (total 173 wild dogs). Out of these 7 M. bovis culture-positive wild dogs, 3 were IGRA positive initially, however, after repeat sampling and testing, 5 out of 7 were IGRA positive. These findings suggest that intraspecies transmission of M. bovis may be possible among wild dogs. Although the risk of intraspecies transmission is currently unknown, this knowledge is important for assessing the risk of M. bovis transmission from infected wild dogs to uninfected populations during translocations.
- Published
- 2021
9. Epidemiology of Tuberculosis in Multi-Host Wildlife Systems: Implications for Black (Diceros bicornis) and White (Ceratotherium simum) Rhinoceros
- Author
-
Carmel Witte, Michele A. Miller, Wynand J. Goosen, Rebecca A. Dwyer, and Peter Buss
- Subjects
Tuberculosis ,040301 veterinary sciences ,Zoology ,Rhinoceros ,0403 veterinary science ,03 medical and health sciences ,medicine ,TB transmission ,rhinoceros ,030304 developmental biology ,Black rhinoceros ,0303 health sciences ,Mycobacterium bovis ,lcsh:Veterinary medicine ,biology ,General Veterinary ,Transmission (medicine) ,Ceratotherium simum ,04 agricultural and veterinary sciences ,medicine.disease ,biology.organism_classification ,TB risk ,Tragelaphus strepsiceros ,Mycobacterium tuberculosis complex ,tuberculosis ,lcsh:SF600-1100 ,epidemiology - Abstract
Cases of tuberculosis (TB) resulting from infection with Mycobacterium tuberculosis complex (MTBC) have been recorded in captive white (Ceratotherium simum) and black (Diceros bicornis) rhinoceros. More recently, cases have been documented in free-ranging populations of both species in bovine tuberculosis (bTB) endemic areas of South Africa. There is limited information on risk factors and transmission patterns for MTBC infections in African rhinoceros, however, extrapolation from literature on MTBC infections in other species and multi-host systems provides a foundation for understanding TB epidemiology in rhinoceros species. Current diagnostic tests include blood-based immunoassays but distinguishing between subclinical and active infections remains challenging due to the lack of diagnostic techniques. In other species, demographic risk factors for MTBC infection include sex and age, where males and adults are generally at higher risk than females and younger individuals. Limited available historical information reflects similar age- and sex-associated patterns for TB in captive black and white rhinoceros, with more reports of MTBC-associated disease in black rhinoceros than in white rhinoceros. The degree of MTBC exposure in susceptible wildlife depends on their level of interaction, either directly with other infected individuals or indirectly through MTBC contaminated environments, which is dependent on the presence and abundance of infected reservoir hosts and the amount of MTBC shed in their excreta. Captive African rhinoceros have shown evidence of MTBC shedding, and although infection levels are low in free-ranging rhinoceros, there is a risk for intraspecies transmission. Free-ranging rhinoceros in bTB endemic areas may be exposed to MTBC from other infected host species, such as the African buffalo (Syncerus caffer) and greater kudu (Tragelaphus strepsiceros), through shared environmental niches, and resource co-utilization. This review describes current knowledge and information gaps regarding the epidemiology of TB in African rhinoceros.
- Published
- 2020
- Full Text
- View/download PDF
10. Review of Diagnostic Tests for Detection of
- Author
-
Konstantin P. Lyashchenko, Sven D.C. Parsons, Charlene Clarke, Katrin Smith, Robin M. Warren, Michele A. Miller, Taschnica T Sylvester, David Cooper, Candice R. de Waal, Anzaan Dippenaar, Wynand J. Goosen, Christina Meiring, Paul D. van Helden, Léanie Kleynhans, Tanya J. Kerr, Peter Buss, Samantha Goldswain, Rachiel Gumbo, Eduard O. Roos, Netanya Bernitz, Roxanne L. Higgitt, and Josephine Chileshe
- Subjects
0301 basic medicine ,Tuberculosis ,040301 veterinary sciences ,Wildlife ,Zoology ,Review ,Disease ,immunological assays ,direct detection of mycobacteria ,0403 veterinary science ,03 medical and health sciences ,diagnostics ,Bovine tuberculosis ,medicine ,South African wildlife ,bovine tuberculosis ,Mycobacterium bovis ,gene expression assays ,lcsh:Veterinary medicine ,biology ,General Veterinary ,business.industry ,Diagnostic test ,04 agricultural and veterinary sciences ,medicine.disease ,biology.organism_classification ,cytokine release assays ,030104 developmental biology ,lcsh:SF600-1100 ,Veterinary Science ,Livestock ,Identification (biology) ,business - Abstract
Wildlife tuberculosis is a major economic and conservation concern globally. Bovine tuberculosis (bTB), caused byMycobacterium bovis(M. bovis), is the most common form of wildlife tuberculosis. In South Africa, to date,M. bovisinfection has been detected in 24 mammalian wildlife species. The identification ofM. bovisinfection in wildlife species is essential to limit the spread and to control the disease in these populations, sympatric wildlife species and neighboring livestock. The detection ofM. bovis-infected individuals is challenging as only severely diseased animals show clinical disease manifestations and diagnostic tools to identify infection are limited. The emergence of novel reagents and technologies to identifyM. bovisinfection in wildlife species are instrumental in improving the diagnosis and control of bTB. This review provides an update on the diagnostic tools to detectM. bovisinfection in South African wildlife but may be a useful guide for other wildlife species.
- Published
- 2020
11. The VetMAXTM M. tuberculosis Complex PCR Kit detects MTBC DNA in antemortem and postmortem samples from white rhinoceros (Ceratotherium simum), African elephants (Loxodonta africana) and African buffaloes (Syncerus caffer)
- Author
-
Wynand J. Goosen, Tanya J. Kerr, Bjorn Schroder, Sven D.C. Parsons, Michele A. Miller, Peter Buss, Paul D. van Helden, David Cooper, Léanie Kleynhans, and Robin M. Warren
- Subjects
Tuberculosis ,Buffaloes ,Elephants ,Rhinoceros ,Real-Time Polymerase Chain Reaction ,law.invention ,Mycobacterium tuberculosis ,chemistry.chemical_compound ,African buffaloes ,law ,medicine ,Animals ,Polymerase chain reaction ,Perissodactyla ,Mycobacterium bovis ,lcsh:Veterinary medicine ,General Veterinary ,biology ,Ceratotherium simum ,Methodology Article ,African elephants ,General Medicine ,VetMAX™ MTBC detection kit qPCR, white rhinoceros ,DNA ,biology.organism_classification ,medicine.disease ,Virology ,PCR ,Mycobacterium tuberculosis complex ,chemistry ,lcsh:SF600-1100 - Abstract
Background Bovine tuberculosis and tuberculosis are chronic infectious diseases caused by the Mycobacterium tuberculosis complex members, Mycobacterium bovis and Mycobacterium tuberculosis, respectively. Infection with M. bovis and M. tuberculosis have significant implications for wildlife species management, public health, veterinary disease control, and conservation endeavours. Results Here we describe the first use of the VetMAX™ Mycobacterium tuberculosis complex (MTBC) DNA quantitative real-time polymerase chain reaction (qPCR) detection kit for African wildlife samples. DNA was extracted from tissues harvested from 48 African buffaloes and MTBC DNA was detected (test-positive) in all 26 M. bovis culture-confirmed animals with an additional 12 PCR-positive results in culture-negative buffaloes (originating from an exposed population). Of six MTBC-infected African rhinoceros tested, MTBC DNA was detected in antemortem and postmortem samples from five animals. The PCR was also able to detect MTBC DNA in samples from two African elephants confirmed to have M. bovis and M. tuberculosis infections (one each). Culture-confirmed uninfected rhinoceros and elephants’ samples tested negative in the PCR assay. Conclusions These results suggest this new detection kit is a sensitive screening test for the detection of MTBC-infected African buffaloes, African elephants and white rhinoceros.
- Published
- 2020
12. Antigen-specific interferon-gamma release is decreased following the single intradermal comparative cervical skin test in African buffaloes (Syncerus caffer)
- Author
-
Robin M. Warren, Wynand J. Goosen, Sven D.C. Parsons, Michele A. Miller, P. D. van Helden, R. McFadyen, Dave Cooper, and Charlene Clarke
- Subjects
0301 basic medicine ,Tuberculosis ,Buffaloes ,040301 veterinary sciences ,Immunology ,Interferon gamma release assay ,Tuberculin ,Physiology ,Animals, Wild ,Biology ,Sensitivity and Specificity ,0403 veterinary science ,Interferon-gamma ,03 medical and health sciences ,Antigen ,Antigen specific ,parasitic diseases ,medicine ,Animals ,Interferon gamma ,Antigens, Bacterial ,General Veterinary ,Tuberculin Test ,04 agricultural and veterinary sciences ,Blood collection ,Skin test ,Intradermal Tests ,bacterial infections and mycoses ,medicine.disease ,Mycobacterium bovis ,030104 developmental biology ,Cattle ,Tuberculosis, Bovine ,Interferon-gamma Release Tests ,medicine.drug - Abstract
Effective disease management of wildlife relies on the strategic application of ante-mortem diagnostic tests for early identification and removal of M. bovis-infected animals. To improve diagnostic performance, interferon-gamma release assays (IGRAs) are often used in conjunction with the tuberculin skin test (TST). Since buffaloes are major maintenance hosts of M. bovis, optimal application of bovine TB diagnostic tests are especially important. We aimed to determine whether the timing of blood collection relative to the TST has an influence on IFN-γ production and diagnostic outcome in African buffaloes. Release of IFN-γ in response to bovine purified protein derivative (PPD), avian PPD and PC-HP® and PC-EC® peptides was measured by Bovigam® and an in-house IGRA in a group of Bovigam®-positive and – negative buffaloes at the time the TST was performed and three days later. There was significantly lower IFN-γ release in response to these antigens post-TST in Bovigam®-positive buffaloes, but no significant changes in Bovigam®-negative buffaloes. Also, a significantly greater proportion of buffaloes were Bovigam®-positive prior to the TST than three days later. We therefore recommend that blood samples for use in IGRAs be collected prior to or at the time the TST is performed to facilitate the correct identification of greater numbers of IGRA-positive buffaloes.
- Published
- 2018
13. Detection of Mycobacterium bovis infection in African buffaloes ( Syncerus caffer ) using QuantiFERON ® -TB Gold (QFT) tubes and the Qiagen cattletype ® IFN-gamma ELISA
- Author
-
Netanya Bernitz, Eduard O. Roos, Wynand J. Goosen, Sven D.C. Parsons, David Cooper, Charlene Clarke, Michele A. Miller, and Paul D. van Helden
- Subjects
0301 basic medicine ,Mycobacterium bovis ,General Veterinary ,biology ,040301 veterinary sciences ,QUANTIFERON-TB GOLD ,Immunology ,Intradermal skin test ,Interferon gamma release assay ,04 agricultural and veterinary sciences ,biology.organism_classification ,Virology ,QuantiFERON ,Incubation period ,0403 veterinary science ,03 medical and health sciences ,030104 developmental biology ,Bovine tuberculosis ,Ifn gamma - Abstract
African buffaloes (Syncerus caffer) are wildlife maintenance hosts of Mycobacterium bovis, the cause of bovine tuberculosis. Consequently, M. bovis infected buffaloes pose a transmission risk for cattle and other wildlife species. Previously, a modification to the Qiagen QuantiFERON®-TB Gold (QFT) system, using QFT tubes and an in-house bovine interferon-gamma (IFN-γ) ELISA, was evaluated for the detection of M. bovis infection in buffaloes. Subsequently, Qiagen has developed a commercially available cattletype® IFN-gamma ELISA for the detection of antigen-specific IFN-γ release in ruminants. The aim of this study was to investigate the use of QFT tubes and the cattletype® IFN-gamma ELISA, in a cattletype IFN-γ release assay (IGRA), to detect M. bovis infection in African buffaloes. The test agreements between the cattletype IGRA, single comparative intradermal skin test (SCITT) and Bovigam® 1G IGRA in two M. bovis-exposed buffalo populations (n = 134 and n = 92) were calculated and κ coefficients ranged from 0.65 (95% CI 0.48–0.82) to 0.86 (95% CI 0.72–0.99). Increasing the QFT incubation time in one M. bovis-exposed buffalo cohort (n = 92), from 20 to 40 h, had no effect on the cattletype IGRA test results. Inter-assay and intra-assay reproducibility determination for the cattletype IGRA produced coefficient of variations (CV)
- Published
- 2018
14. An interferon-gamma release assay for the diagnosis of the Mycobacterium bovis infection in white rhinoceros (Ceratotherium simum)
- Author
-
Josephine Chileshe, Michele A. Miller, Eduard O. Roos, Sven Dc Parsons, Robin M. Warren, Paul D. van Helden, Wynand J. Goosen, Tebogo Manemela, Guy Hausler, Leana Rossouw, and Peter Buss
- Subjects
040301 veterinary sciences ,Immunology ,Population ,Interferon gamma release assay ,Rhinoceros ,Enzyme-Linked Immunosorbent Assay ,0403 veterinary science ,03 medical and health sciences ,Interferon-gamma ,South Africa ,Tuberculosis diagnosis ,medicine ,Animals ,Tuberculosis ,Interferon gamma ,education ,Perissodactyla ,030304 developmental biology ,Whole blood ,0303 health sciences ,education.field_of_study ,Mycobacterium bovis ,General Veterinary ,biology ,Ceratotherium simum ,04 agricultural and veterinary sciences ,biology.organism_classification ,Virology ,Reagent Kits, Diagnostic ,Interferon-gamma Release Tests ,medicine.drug - Abstract
Mycobacterium bovis (M. bovis), the cause of bovine tuberculosis, is endemic in Kruger National Park (KNP), South Africa. The risk of spread of M. bovis infection currently prevents translocation of white rhinoceros (Ceratotherium simum) from this population. Therefore, accurate assays are necessary for screening this threatened species. Interferon gamma (IFN-γ) release assays (IGRA) are commonly used for tuberculosis diagnosis in humans and other wildlife species. Hence, the aim of this study was to develop an IGRA for M. bovis detection in white rhinoceros. Heparinized whole blood was collected from immobilized white rhinoceros in KNP (n = 131) and incubated overnight in QuantiFERON®-TB Gold (QFT) blood collection tubes, after which the plasma was harvested following centrifugation. Tissue samples for mycobacterial culture were available from a subset of 21 rhinoceros. The concentration of IFN-γ in plasma samples was measured using the Mabtech equine IFN-γ ELISAPRO kit. An IGRA result was calculated as the difference in IFN-γ concentrations in the QFT Nil and TB antigen tubes. Using test results for the white rhinoceros with known infection status, a diagnostic cut-off value was calculated as 21 pg/ml. Additionally, cut-off values for IFN-γ concentrations for plasma from QFT Nil and QFT Mitogen tubes were calculated to increase confidence in IGRA result interpretation. The combination of the QFT stimulation platform and Mabtech equine IFN-γ ELISA is a promising diagnostic test to distinguish between of M. bovis-infected and -uninfected white rhinoceros.
- Published
- 2019
15. Use of the MILLIPLEX® bovine cytokine/chemokine multiplex assay to identify Mycobacterium bovis-infection biomarkers in African buffaloes (Syncerus caffer)
- Author
-
David Cooper, Paul D. van Helden, Candice I. Snyders, Robin M. Warren, Netanya Bernitz, Wynand J. Goosen, Léanie Kleynhans, Katrin Smith, and Michele A. Miller
- Subjects
0303 health sciences ,Mycobacterium bovis ,Chemokine ,General Veterinary ,040301 veterinary sciences ,Transmission (medicine) ,animal diseases ,medicine.medical_treatment ,Immunology ,04 agricultural and veterinary sciences ,Biology ,biology.organism_classification ,0403 veterinary science ,03 medical and health sciences ,Immune system ,Cytokine ,parasitic diseases ,biology.protein ,medicine ,Multiplex ,Antibody ,030304 developmental biology ,Whole blood - Abstract
As a recognized Mycobacterium bovis maintenance host, the African buffalo (Syncerus caffer) poses transmission risks to livestock, humans and other wildlife. Early detection of M. bovis infection is critical for limiting its spread. Currently, tests detecting cell-mediated immune responses are used for diagnosis in buffaloes. However, these may have suboptimal sensitivity or specificity, depending on the blood stimulation method. Recent evidence suggests that assays using combinations of host cytokine biomarkers may increase diagnostic performance. Therefore, this study aimed to investigate the application of a MILLIPLEX® bovine cytokine/chemokine multiplex assay to identify candidate biomarkers of M. bovis infection in buffaloes. Whole blood from twelve culture-confirmed M. bovis-infected buffaloes, stimulated with the QuantiFERON® TB Gold Plus in-tube system, was tested using the MILLIPLEX® platform. Results indicated binding of bovine antibodies to fifteen buffalo cytokine/chemokine targets. Moreover, there was a significant difference in concentrations between unstimulated and TB antigen-stimulated buffalo samples for seven cytokines/chemokines included in the kit. Although these preliminary results require further investigation in larger sample sets and a comparison between M. bovis-infected and uninfected cohorts, the utility of the MILLIPLEX® platform in a novel species was demonstrated, in addition to identifying potential African buffalo cytokines for future research.
- Published
- 2021
16. Optimized interferon-gamma release assays for detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
- Author
-
Wynand J. Goosen, Michele A. Miller, Netanya Bernitz, David Cooper, Robin M. Warren, Samantha Goldswain, and Katrin Smith
- Subjects
Buffaloes ,040301 veterinary sciences ,Immunology ,Interferon gamma release assay ,Early detection ,Enzyme-Linked Immunosorbent Assay ,Biology ,Cohort Studies ,0403 veterinary science ,Interferon-gamma ,03 medical and health sciences ,Immune system ,Antigen ,parasitic diseases ,Bovine tuberculosis ,medicine ,Animals ,Tuberculosis ,Interferon gamma ,030304 developmental biology ,0303 health sciences ,Mycobacterium bovis ,General Veterinary ,04 agricultural and veterinary sciences ,biology.organism_classification ,Virology ,Test performance ,Interferon-gamma Release Tests ,medicine.drug - Abstract
The African buffalo (Syncerus caffer) is an economically and ecologically important wildlife species in South Africa; it is also a primary wildlife maintenance host of Mycobacterium bovis. Accurate and early detection of M. bovis infection in buffaloes is important for controlling transmission. Assays that detect cell-mediated immune responses to M. bovis in buffaloes have been developed although these often display suboptimal sensitivity or specificity. Therefore, the aim of this study was to evaluate the newly available Mabtech bovine interferon-gamma (IFN-γ) ELISAPRO kit and optimize its use for detection of buffalo IFN-γ in whole blood samples stimulated with the QuantiFERON® TB Gold Plus antigens. Additionally, the test performance of the Mabtech IFN-γ release assay (IGRA) was compared to the currently used Cattletype® IGRA by determining buffalo-specific cut-off values for the two IGRAs and using gold standard-positive (M. bovis culture-confirmed) and M. bovis-unexposed negative cohorts. Validation of the Mabtech ELISA revealed negligible matrix interference and a linear and parallel response for recombinant bovine and native buffalo IFN-γ in the range 1.95–250 pg/mL. Intra- and inter-assay reproducibility produced coefficients of variation
- Published
- 2021
17. The stability of plasma IP-10 enhances its utility for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
- Author
-
Paul D. van Helden, Michele A. Miller, Wynand J. Goosen, Robin M. Warren, and Sven D.C. Parsons
- Subjects
0301 basic medicine ,Buffaloes ,medicine.medical_treatment ,030106 microbiology ,Immunology ,Biology ,Microbiology ,03 medical and health sciences ,Interferon ,medicine ,Animals ,Tuberculosis ,Saline ,Incubation ,Phytohaemagglutinin ,Whole blood ,Mycobacterium bovis ,General Veterinary ,Protein Stability ,biology.organism_classification ,Virology ,Chemokine CXCL10 ,Heat inactivation ,030104 developmental biology ,biology.protein ,Heat treated ,Biomarkers ,medicine.drug - Abstract
The measurement of interferon gamma-induced protein 10 (IP-10) in antigen-stimulated whole blood is a sensitive biomarker of Mycobacterium bovis infection in African buffaloes (Syncerus caffer). However, this species often occurs in remote locations and diagnostic samples must be transported to centralised laboratories for processing. In humans, plasma IP-10 is highly stable and this feature contributes to its diagnostic utility; for this reason we aimed to characterize the stability of this molecule in buffaloes. Blood from M. bovis-infected and -uninfected animals was incubated with pathogen-specific peptides, saline and phytohaemagglutinin, respectively. Plasma fractions were harvested and aliquots of selected samples were: (i) stored at different temperatures for various times; (ii) heat treated before storage at RT, and (iii) stored on Protein Saver Cards (PSCs) at RT for either 2 or 8 weeks before measurement of IP-10. Incubation of plasma at 65°C for 20 min caused no loss of IP-10 and this protein could be quantified in plasma stored on PSCs for 2 and 8 weeks. Moreover, for all storage conditions, IP-10 retained its excellent diagnostic characteristics. These features of IP-10 might allow for the heat inactivation of potentially infectious plasma which would facilitate the safe and simple transport of samples.
- Published
- 2016
18. Impact of Mycobacterium bovis-induced pathology on interpretation of QuantiFERON®-TB Gold assay results in African buffaloes (Syncerus caffer)
- Author
-
Michele A. Miller, Paul D. van Helden, Netanya Bernitz, Roxanne L. Higgitt, Candice R. de Waal, Tanya J. Kerr, Sven D.C. Parsons, Charlene Clarke, Robin M. Warren, David Cooper, and Wynand J. Goosen
- Subjects
Buffaloes ,QUANTIFERON-TB GOLD ,medicine.medical_treatment ,Immunology ,Biology ,Sensitivity and Specificity ,Microbiology ,Interferon-gamma ,Interferon ,parasitic diseases ,Bovine tuberculosis ,medicine ,Animals ,Interferon gamma ,Whole blood ,Mycobacterium bovis ,General Veterinary ,biology.organism_classification ,Chemokine CXCL10 ,Cytokine ,Biomarker (medicine) ,Cattle ,Reagent Kits, Diagnostic ,Tuberculosis, Bovine ,Interferon-gamma Release Tests ,medicine.drug - Abstract
The cytokine interferon gamma-inducible protein 10 (IP-10) is a sensitive biomarker of Mycobacterium bovis (M. bovis) infection in African buffaloes (Syncerus caffer). However, elevated levels of IP-10 in QuantiFERON®-TB Gold (QFT) unstimulated whole blood compromises the utility of this biomarker. In this study, IP-10 and interferon gamma (IFN-γ) concentrations in whole blood samples from M. bovis culture-confirmed buffaloes with varying degrees of pathological changes (n = 72) and uninfected controls (n = 70) were measured in the IP-10 release assay (IPRA) and IFN-γ release assay (IGRA), respectively. Findings suggest that concentrations of both cytokines in QFT Nil tubes were higher in infected buffaloes with macroscopic pathological changes consistent with bovine tuberculosis compared to uninfected controls, and IGRA values increased with more severe pathological changes in infected buffaloes (p 0.05). Finally, in culture-confirmed buffaloes with IPRA-negative and IGRA-positive test results, most animals were also those with the most advanced pathology. We conclude that IP-10 and IFN-γ concentrations measured in QFT Nil tubes may provide insight into the presence of M. bovis pathology in infected buffaloes. Furthermore, this study highlights the value in evaluating cytokine production in both antigen-stimulated and unstimulated samples when interpreting cytokine release assay results.
- Published
- 2019
19. TB Control in Humans and Animals in South Africa: A Perspective on Problems and Successes
- Author
-
Christina Meiring, Wynand J. Goosen, and Paul D. van Helden
- Subjects
zoonotic TB ,Tuberculosis ,040301 veterinary sciences ,infectious diseases ,0403 veterinary science ,Mycobacterium tuberculosis ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,medicine ,030212 general & internal medicine ,bovine TB ,Mycobacterium bovis ,lcsh:Veterinary medicine ,General Veterinary ,biology ,Tb control ,business.industry ,04 agricultural and veterinary sciences ,medicine.disease ,biology.organism_classification ,Human morbidity ,tuberculosis ,Infectious disease (medical specialty) ,Perspective ,lcsh:SF600-1100 ,Veterinary Science ,High incidence ,business ,Limited resources - Abstract
Mycobacterium tuberculosis (M. tb) remains one of the most globally serious infectious agents for human morbidity and mortality, but with significant differences in prevalence across the globe. In many countries, the incidence is now low and declining, but control and eradication remain a distant view. Similarly, the prevalence of bovine TB caused by Mycobacterium bovis (M. bovis), varies significantly across regions, although unlike for M. tuberculosis, data are sparse. The reduction in incidence and prevalence and control of both human and bovine TB is difficult and costly, yet some countries have managed to do this with some success. This perspective will consider some of the critical control steps we now know to be important for the control of TB from M. tuberculosis in humans living in South Africa, where the incidence of TB is the highest currently experienced. Despite the high incidence of human TB, South Africa has been able to reduce this incidence remarkably in the past few years, despite limited resources and high HIV prevalence. We draw from our experience to ascertain whether we may learn useful lessons from control efforts for both diseases in order to suggest effective control measures for bovine TB.
- Published
- 2018
20. The evaluation of candidate biomarkers of cell-mediated immunity for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
- Author
-
Robin M. Warren, Paul D. van Helden, Michele A. Miller, David Cooper, Wynand J. Goosen, and Sven D.C. Parsons
- Subjects
Buffaloes ,medicine.medical_treatment ,Immunology ,Enzyme-Linked Immunosorbent Assay ,Biology ,Chemokine CXCL9 ,Statistics, Nonparametric ,Immune system ,medicine ,Animals ,Interferon gamma ,chemistry.chemical_classification ,Mycobacterium bovis ,Messenger RNA ,Immunity, Cellular ,Mycobacterium Infections ,General Veterinary ,biology.organism_classification ,Virology ,Amino acid ,Monocyte Chemoattractant Proteins ,Chemokine CXCL10 ,Interleukin 1 Receptor Antagonist Protein ,Enzyme ,Cytokine ,chemistry ,Cattle ,Biomarkers ,Mycobacterium ,medicine.drug - Abstract
We evaluated commercially available bovine enzyme linked immunosorbent assays (ELISA) and a human IP-10 ELISA to measure IP-10, MIG, MCP-1, MCP-2, MCP-3 and IL1-RA in buffalo plasma in order to identify sensitive markers of the immune response to Mycobacterium bovis-specific peptides. Additionally, we found that all coding mRNA sequences of these cytokines showed very high homology with their homologues in domestic cattle (97-99%) as did the derived amino acid sequences (97-99%). This high sequence homology between cattle and buffaloes supports the use of bovine ELISAs for the detection these cytokines in buffaloes. MCP-1 concentration showed a positive correlation with that of IFN-γ (p=0.0077) and appears to occur in far greater abundance in buffaloes when compared to humans. Using a bovine IP-10 ELISA, levels of this cytokine were found to be significantly increased in antigen-stimulated blood samples from M. bovis test positive buffaloes (p
- Published
- 2014
21. Agreement between assays of cell-mediated immunity utilizing Mycobacterium bovis-specific antigens for the diagnosis of tuberculosis in African buffaloes (Syncerus caffer)
- Author
-
Sven D.C. Parsons, Novel N. Chegou, Robin M. Warren, Paul D. van Helden, David Cooper, Michele A. Miller, and Wynand J. Goosen
- Subjects
Mycobacterium bovis ,Antigens, Bacterial ,Immunity, Cellular ,CFP-10 ,Tuberculosis ,General Veterinary ,biology ,Buffaloes ,Tuberculin Test ,Immunology ,biology.organism_classification ,medicine.disease ,Virology ,Microbiology ,Interferon-gamma ,Antigen ,ESAT-6 ,medicine ,Animals ,Interferon gamma ,medicine.drug ,Mycobacterium ,Whole blood - Abstract
We assessed the use of Mycobacterium bovis-specific peptides for the diagnosis of tuberculosis in African buffaloes (Syncerus caffer) by evaluating the agreement between the single intradermal comparative tuberculin test (SICTT), the Bovigam® EC (BEC) assay, the Bovigam® HP (BHP) assay and two assays utilizing the QuantiFERON® TB-Gold (in tube) system employing 20 h (mQFT20 assay) and 30 h (mQFT30 assay) whole blood incubation periods. Of 84 buffaloes, 45% were SICTT-positive, 48% were BEC-positive, 50% were BHP-positive, 37% were mQFT20-positive and 43% were mQFT30-positive. Agreement between the BEC and BHP Bovigam® assays was high (κ = 0.86, 95% CI 0.75–0.97) and these detected the most test-positive animals suggesting that they were the most sensitive assays. Interferon-gamma release was significantly greater in buffaloes that were test-positive for all tests than in animals with discordant but positive Bovigam® results. Agreement between the mQFT assays was equally high (κ = 0.88, 95% CI 0.77–0.98); however, all buffaloes with discordant mQFT results (n = 6) were mQFT30-positive/mQFT20-negative, including three confirmed M. bovis-infected animals, suggesting that the mQFT30 assay is the more sensitive of the two. Agreements between the two Bovigam® and two mQFT assays were moderate, suggesting that in its current format the mQFT assay is less sensitive than either the BEC or the BHP assays.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.